Includes Interferon gamma-1b, marketed as Actimmune.
Sites 2
- Actimmune: Interferon gamma-1b Manufacturer's information about this protein agent approved by the US FDA for the treatment of chronic granulomatous disease, and severe, malignant osteopetrosis.
- MedlinePlus: Interferon Gamma-1b Injection Features information about dosage, usage, warnings, and side effects.